Capacity Expansion Stallergenes Greer is accelerating manufacturing capacity in France and Western Europe with large-scale euro investments, signaling rising regional demand for allergen immunotherapy and creating opportunities for regional supply partnerships and contract manufacturing.

Venom Immunotherapy Acquisition of Entomon s.r.l. expands venom immunotherapy production and diagnostic extract capabilities, opening potential for supply agreements, joint development of VIT products, and expanded distribution in Europe.

Clinical Leadership EAACI congress participation and presentation of new long-term outcomes demonstrates a strong clinical evidence platform, offering opportunities for post-market studies, payer engagement, and co-marketing with healthcare providers.

Global Market Access Operations in 45 countries with manufacturing in Europe and the United States provide a broad market access base for multi-country distribution deals, regulatory support, and local partnerships in key regions.

Digital Platform A mature tech stack including SAP ECC, Coupa and Power BI, plus GDPR compliance, positions the company to optimize procurement, ERP integration, and analytics-driven planning as investments scale.